State of Wyoming’s Autolus Therapeutics AUTL Stock Holding History

State of Wyoming’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$714	–	1615
2023 Q2	$714	Buy	300 +90	+43%	+$214	﹤0.01%	1522
2023 Q1	$386	Sell	210 -8	-4%	-$16	﹤0.01%	1554
2022 Q4	$414	Buy	218 +167	+327%	+$422	﹤0.01%	1529
2022 Q3	$0	Buy	+51	New	+$151	﹤0.01%	1540
2021 Q3	–	Sell	-39	Closed	–	–	1221
2021 Q2	$0	Buy	+39	New	+$242	﹤0.01%	1175

Other funds holding AUTL

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

State of Wyoming's AUTL Position: Q3 2023 in Review

State of Wyoming sold out of Autolus Therapeutics (AUTL) in Q3 2023, closing a stake of 300 shares — an estimated $714 sold.

State of Wyoming first reported a position in AUTL in Q2 2021 and held it in 5 quarters. The position peaked at $714 in Q2 2023. 71 funds tracked by Wall St. Rank hold AUTL as of Q3 2023.

State of Wyoming reported no remaining Autolus Therapeutics position as of Q3 2023 after selling out during the quarter.
State of Wyoming sold 300 Autolus Therapeutics shares in Q3 2023, an estimated $714.
State of Wyoming first reported a position in Autolus Therapeutics in Q2 2021 and held it in 5 quarters.
State of Wyoming's Autolus Therapeutics position peaked at $714 in Q2 2023.
71 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2023.

Based on State of Wyoming's 13F filing for Q3 2023, filed 14 Nov 2023.